Literature DB >> 33721061

Role of CMR feature-tracking derived left ventricular strain in predicting myocardial iron overload and assessing myocardial contractile dysfunction in patients with thalassemia major.

Vineeta Ojha1, Kartik P Ganga1, Tulika Seth2, Ambuj Roy3, Nitish Naik3, Priya Jagia1, Gurpreet S Gulati1, Sanjeev Kumar4, Sanjiv Sharma1.   

Abstract

OBJECTIVE: Myocardial iron overload (MIO) in thalassemia major (TM) may cause subclinical left ventricular (LV) dysfunction which manifests with abnormal strain parameters before a decrease in ejection fraction (EF). Early detection of MIO using cardiovascular magnetic resonance (CMR)-T2* is vital. Our aim was to assess if CMR feature-tracking (FT) strain correlates with T2*, and whether it can identify early contractile dysfunction in patients with MIO but normal EF.
METHODS: One hundred and four consecutive TM patients with LVEF > 55% on echocardiography were prospectively enrolled. Those fulfilling the inclusion criteria underwent CMR, with T2* being the gold standard for detecting MIO. Group 1 included patients without significant MIO (T2* > 20 ms) and group 2 with significant MIO (T2* < 20 ms).
RESULTS: Eighty-six patients (mean age, 17.32 years, 59 males) underwent CMR. There were 68 (79.1%) patients in group 1 and 18 (20.9%) in group 2. Fourteen patients (16.3%) had mild-moderate MIO, and four (4.6%) had severe MIO. Patients in group 2 had significantly lower global radial strain (GRS). Global longitudinal strain (GLS) and global circumferential strain (GCS) did not correlate with T2*. T1 mapping values were significantly lower in patients with T2* < 10 ms than those with T2* of 10-20 ms; however, FT-strain values were not significantly different between these two groups.
CONCLUSION: CMR-derived GRS, but not GLS and GCS, correlated with CMR T2*. GRS is significantly decreased in TM patients with MIO and normal EF when compared with those without. FT-strain may be a useful adjunct to CMR T2* and maybe an early marker of myocardial dysfunction in TM. KEY POINTS: • A global radial strain of < 29.3 derived from cardiac MRI could predict significant myocardial iron overload in patients with thalassemia, with a sensitivity of 76.5% and specificity of 66.7%. • Patients with any myocardial iron overload have significantly lower GRS, compared to those without, suggesting the ability of CMR strain to identify subtle myocardial contractile disturbances. • T1 and T2 mapping values are significantly lower in those with severe myocardial iron than those with mild-moderate iron, suggesting a potential role of T1 and T2 mapping in grading myocardial iron.
© 2020. European Society of Radiology.

Entities:  

Keywords:  Cardiomyopathy; Iron overload; Magnetic resonance imaging; Ventricular dysfunction, left; beta-Thalassemia

Mesh:

Year:  2021        PMID: 33721061     DOI: 10.1007/s00330-020-07599-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  43 in total

Review 1.  Practical management of iron overload.

Authors:  J B Porter
Journal:  Br J Haematol       Date:  2001-11       Impact factor: 6.998

2.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

Authors:  L J Anderson; S Holden; B Davis; E Prescott; C C Charrier; N H Bunce; D N Firmin; B Wonke; J Porter; J M Walker; D J Pennell
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

Review 3.  Iron overload cardiomyopathy in clinical practice.

Authors:  Dimitrios T Kremastinos; Dimitrios Farmakis
Journal:  Circulation       Date:  2011-11-15       Impact factor: 29.690

4.  Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia.

Authors:  Athanassios Aessopos; Christina Fragodimitri; Fotios Karabatsos; Antonia Hatziliami; Jacqueline Yousef; Anastasios Giakoumis; Aikaterini Dokou; Efstathios D Gotsis; Vasilis Berdoukas; Markissia Karagiorga
Journal:  Haematologica       Date:  2007-01       Impact factor: 9.941

Review 5.  Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment.

Authors:  Colm J Murphy; Gavin Y Oudit
Journal:  J Card Fail       Date:  2010-07-03       Impact factor: 5.712

6.  On T2* magnetic resonance and cardiac iron.

Authors:  John-Paul Carpenter; Taigang He; Paul Kirk; Michael Roughton; Lisa J Anderson; Sofia V de Noronha; Mary N Sheppard; John B Porter; J Malcolm Walker; John C Wood; Renzo Galanello; Gianluca Forni; Gualtiero Catani; Gildo Matta; Suthat Fucharoen; Adam Fleming; Michael J House; Greg Black; David N Firmin; Timothy G St Pierre; Dudley J Pennell
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

7.  Evaluation of the efficacy of oral deferiprone in beta-thalassemia major by multislice multiecho T2*.

Authors:  Alessia Pepe; Massimo Lombardi; Vincenzo Positano; Eliana Cracolici; Marcello Capra; Roberto Malizia; Luciano Prossomariti; Daniele De Marchi; Massimo Midiri; Aurelio Maggio
Journal:  Eur J Haematol       Date:  2006-03       Impact factor: 2.997

8.  Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

Authors:  Caterina Borgna-Pignatti; Simone Rugolotto; Piero De Stefano; Huaqing Zhao; Maria Domenica Cappellini; Giovanni Carlo Del Vecchio; Maria Antonietta Romeo; Gian Luca Forni; Maria Rita Gamberini; Roberta Ghilardi; Antonio Piga; Avital Cnaan
Journal:  Haematologica       Date:  2004-10       Impact factor: 9.941

9.  Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major.

Authors:  P Kirk; M Roughton; J B Porter; J M Walker; M A Tanner; J Patel; D Wu; J Taylor; M A Westwood; L J Anderson; D J Pennell
Journal:  Circulation       Date:  2009-10-02       Impact factor: 29.690

10.  Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.

Authors:  Dudley J Pennell; James E Udelson; Andrew E Arai; Biykem Bozkurt; Alan R Cohen; Renzo Galanello; Timothy M Hoffman; Michael S Kiernan; Stamatios Lerakis; Antonio Piga; John B Porter; John Malcolm Walker; John Wood
Journal:  Circulation       Date:  2013-06-17       Impact factor: 29.690

View more
  1 in total

1.  Significance of Cardiac Magnetic Resonance Feature Tracking of the Right Ventricle in Predicting Subclinical Dysfunction in Patients with Thalassemia Major.

Authors:  Karuna M Das; Usama M A Baskaki; Anisha Pulinchani; Huthaifa M Ali; Taleb M Almanssori; Klaus Van Gorkom; Amrita Das; Hany Dewedar; Sanjiv Sharma
Journal:  Diagnostics (Basel)       Date:  2022-08-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.